JP2004519475A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519475A5
JP2004519475A5 JP2002567137A JP2002567137A JP2004519475A5 JP 2004519475 A5 JP2004519475 A5 JP 2004519475A5 JP 2002567137 A JP2002567137 A JP 2002567137A JP 2002567137 A JP2002567137 A JP 2002567137A JP 2004519475 A5 JP2004519475 A5 JP 2004519475A5
Authority
JP
Japan
Prior art keywords
interferon
pharmaceutical composition
composition according
antibody
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519475A (ja
JP4394350B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/000343 external-priority patent/WO2002067760A2/en
Publication of JP2004519475A publication Critical patent/JP2004519475A/ja
Publication of JP2004519475A5 publication Critical patent/JP2004519475A5/ja
Application granted granted Critical
Publication of JP4394350B2 publication Critical patent/JP4394350B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002567137A 2001-01-09 2002-01-08 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ Expired - Fee Related JP4394350B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26054101P 2001-01-09 2001-01-09
PCT/US2002/000343 WO2002067760A2 (en) 2001-01-09 2002-01-08 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009063336A Division JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Publications (3)

Publication Number Publication Date
JP2004519475A JP2004519475A (ja) 2004-07-02
JP2004519475A5 true JP2004519475A5 (https=) 2007-05-10
JP4394350B2 JP4394350B2 (ja) 2010-01-06

Family

ID=22989575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002567137A Expired - Fee Related JP4394350B2 (ja) 2001-01-09 2002-01-08 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
JP2009063336A Withdrawn JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009063336A Withdrawn JP2009132736A (ja) 2001-01-09 2009-03-16 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ

Country Status (14)

Country Link
US (3) US7544357B2 (https=)
EP (2) EP2236156A3 (https=)
JP (2) JP4394350B2 (https=)
KR (1) KR100951409B1 (https=)
CN (2) CN101612402A (https=)
AT (1) ATE502648T1 (https=)
AU (1) AU2002246955B2 (https=)
BR (1) BR0206364A (https=)
CA (1) CA2433806C (https=)
DE (1) DE60239522D1 (https=)
DK (1) DK1351707T3 (https=)
ES (1) ES2363761T3 (https=)
MX (1) MXPA03006100A (https=)
WO (1) WO2002067760A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206364A (pt) * 2001-01-09 2005-08-16 Baylor Res Inst Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
WO2005060992A1 (en) * 2003-12-24 2005-07-07 The Walter And Eliza Hall Institute Of Medical Research Therapeutic agents and uses therefor
HUE035082T2 (en) 2004-06-21 2018-05-02 Squibb & Sons Llc Interferon alpha receptor 1 antibodies and their use
CN103251953A (zh) * 2004-07-19 2013-08-21 约翰·霍普金斯大学 供免疫抑制的flt3抑制剂
BRPI0516470A (pt) * 2004-10-07 2008-09-09 Universitot Zuerich uso de um agente de bloqueio do interferon tipo i, e, método de prevenção e tratamento da psorìase
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
WO2006086586A2 (en) * 2005-02-10 2006-08-17 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
EP2076590A4 (en) * 2007-05-03 2011-06-01 Medimmune Llc SELF-IMMUNE DISEASE SELF-ANTIBODY MARKERS
DK2240781T3 (en) 2008-01-18 2018-03-26 Harvard College METHODS FOR DETECTING DISEASE OR STATE SIGNATURES IN BODY FLUIDS
HRP20160855T1 (hr) 2008-02-08 2016-09-23 Medimmune, Llc Anti-ifnar1 protutijela sa smanjenim afinitetom fc liganda
MX2010012052A (es) 2008-05-07 2010-12-14 Novo Nordisk As Anticuerpos humanizados contra interferon-alfa humano.
WO2010055510A2 (en) * 2008-11-12 2010-05-20 Yeda Research And Development Co. Ltd. Diagnosis of multiple sclerosis
CN101812119B (zh) * 2009-02-25 2012-02-01 上海荣盛生物药业有限公司 与免疫抗体相结合的多肽及其应用
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596134B1 (en) 2010-07-23 2020-04-08 President and Fellows of Harvard College Methods of detecting diseases or conditions using phagocytic cells
CN103384824B (zh) * 2010-12-06 2016-02-03 Thd股份公司 癌症诊断方法及其用途
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
EP2749639B1 (en) * 2012-02-10 2016-10-12 Hakushinkouseikai Foundation Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
KR101536697B1 (ko) * 2013-11-29 2015-07-14 아주대학교산학협력단 베체트병 진단용 조성물
MA40636A (fr) 2014-09-11 2015-09-11 Colleen Kelly Procédés pour détecter le cancer de la prostate
EP3215846B1 (en) 2014-11-05 2020-03-11 Nirmidas Biotech, Inc. Metal composites for enhanced imaging
JP7308034B2 (ja) 2016-07-01 2023-07-13 リゾルブ セラピューティクス， エルエルシー 最適化二重ヌクレアーゼ融合物および方法
BR112020003670A2 (pt) 2017-08-22 2020-09-01 Sanabio, Llc receptores de interferon solúveis e usos dos mesmos
WO2019160976A1 (en) * 2018-02-14 2019-08-22 Viela Bio, Inc. Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases
WO2019204634A1 (en) * 2018-04-20 2019-10-24 Stc. Unm Rap1-gtp, rac1-gtp and fms-like tyrosine kinase 3 ligand (flt3-l) as biomarkers for early detection of sepsis
WO2019241158A1 (en) * 2018-06-11 2019-12-19 Univerity Of Washington Compositions and methods for treating inflammatory diseases
CN113238061B (zh) * 2021-07-09 2021-10-01 中南大学湘雅医院 以cd180阴性b细胞指示重症肌无力病情的试剂盒及应用
CN115032396B (zh) * 2022-06-29 2025-02-21 深圳市康尔诺生物技术有限公司 一种用于预测或判断受试者的肿瘤免疫治疗效果的生物标志物及其应用
CN115678982A (zh) * 2022-09-09 2023-02-03 中山大学 一种用于慢性自身免疫病诊断和/或病种判断的试剂盒
TW202430564A (zh) * 2022-10-20 2024-08-01 英商葛蘭素史密斯克藍智慧財產權有限公司 抗原結合蛋白
WO2025015182A2 (en) * 2023-07-12 2025-01-16 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Compositions and methods for treatment of autoimmunity

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423147A (en) * 1980-04-11 1983-12-27 Secher David S Monoclonal antibody to interferon-α
NZ198445A (en) * 1980-09-25 1984-05-31 Genentech Inc Production of human fibroblast interferon by recombinant dna technology
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
US4456748A (en) * 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
US4605394A (en) * 1982-12-03 1986-08-12 Simon V. Skurkovich Methods for the treatment of pathological conditions by removing interferon from the organism
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
DE3211263A1 (de) * 1981-03-31 1983-01-27 Otsuka Pharmaceutical Co. Ltd., Tokyo Human-interferon verwandte peptide, antigene und antikoerper, sowie verfahren zu deren herstellung
US4678751A (en) * 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
US5096705A (en) * 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5082658A (en) * 1984-01-16 1992-01-21 Genentech, Inc. Gamma interferon-interleukin-2 synergism
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
JPS6330426A (ja) * 1986-07-25 1988-02-09 Mitsubishi Chem Ind Ltd 自己免疫性疾患治療薬
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5254678A (en) * 1987-12-15 1993-10-19 Gene Shears Pty. Limited Ribozymes
AU2844889A (en) 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
US5168053A (en) * 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
US5919452A (en) * 1991-03-18 1999-07-06 New York University Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
AU653937B2 (en) * 1991-04-17 1994-10-20 Medisup International N.V. Water-soluble polypeptides having high affinity for interferons alpha and beta
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
JPH06510061A (ja) * 1991-08-30 1994-11-10 ジェネンテク，インコーポレイテッド Ｉｄｄｍの治療法
US5248499A (en) * 1991-10-07 1993-09-28 Genentech, Inc. Control of microbial infections in transplant patients
EP0563487A1 (en) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
US5888511A (en) * 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
NZ314644A (en) * 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6630143B1 (en) * 1993-05-24 2003-10-07 Immunex Corporation Antibodies against flt3 ligand
CA2171955A1 (en) * 1993-09-17 1995-03-23 Michael G. Tovey Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5780027A (en) * 1995-07-14 1998-07-14 Meiogen Biotechnology Corporation Methods of treatment of down syndrome by interferon antagonists
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
US6713609B1 (en) * 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
US5859183A (en) * 1997-02-13 1999-01-12 The Rockefeller University Altered telomere repeat binding factor
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
ATE428769T1 (de) * 1997-10-27 2009-05-15 Univ Rockefeller Methode und zusammensetzung zur herstellung von reifen dendritischen zellen
EP1037995A1 (en) * 1997-12-08 2000-09-27 Genentech, Inc. Human interferon-epsilon: a type 1 interferon
ZA9811070B (en) * 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
US6291661B1 (en) * 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
US6673908B1 (en) * 1999-02-22 2004-01-06 Nuvelo, Inc. Tumor necrosis factor receptor 2
DE69926920T2 (de) 1999-12-30 2006-06-29 Imclone Systems, Inc. Konservierungsfaktoren von Vorläuferzellen und damit verbundene Verfahren und Produkte
GB0001710D0 (en) 2000-01-25 2000-03-15 Pharma Pacific Pty Ltd Therapeutic treatment
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
WO2002024874A2 (en) * 2000-09-21 2002-03-28 Schering Corporation Methods for preparing interferon producing dentitric cells
BR0206364A (pt) * 2001-01-09 2005-08-16 Baylor Res Inst Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
FR2822845B1 (fr) * 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
US6554512B2 (en) * 2001-04-26 2003-04-29 Zih Corp. Printer for printing deformable flat supports and its loader
KR100872210B1 (ko) 2003-04-23 2008-12-05 메다렉스, 인코포레이티드 인터페론 알파 수용체-1 (ｉｆｎａｒ-1)에 대한 인체화항체
NZ547157A (en) * 2003-12-10 2009-07-31 Medarex Inc Interferon Alpha Antibodies and their uses
BRPI0516470A (pt) 2004-10-07 2008-09-09 Universitot Zuerich uso de um agente de bloqueio do interferon tipo i, e, método de prevenção e tratamento da psorìase

Similar Documents

Publication Publication Date Title
JP2004519475A5 (https=)
CA2433806A1 (en) Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
Saschenbrecker et al. Serological diagnosis of autoimmune bullous skin diseases
Wadhwa et al. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals
Tahara et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders
Corti et al. Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: Effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations
Porta et al. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
Richalet-Sécordel et al. Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation
Suh et al. Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review
JP2013163673A5 (https=)
CA2434512A1 (en) Marker for inflammatory conditions
WO2011095636A1 (en) Method for detecting anti-drug antibodies
Thorpe et al. Current methods for detecting antibodies against erythropoietin and other recombinant proteins
Castagna et al. Hepcidin assay in serum by SELDI-TOF-MS and other approaches
Kakkar et al. Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor
Thorpe et al. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures
Torres et al. Hypersensitivity reactions to beta-lactams
Meager et al. Detection of anti-cytokine antibodies and their clinical relevance
Liparoto et al. Biosensor analysis of the interleukin‐2 receptor complex
WO2003098185A2 (en) Systems and methods for identifying organ transplant risk
US9927443B2 (en) Risk assessment for therapeutic drugs
JP2022545312A (ja) 関節リウマチの診断及び処置の方法
Takacs et al. Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance
Groome et al. Enzyme immunoassays for inhibins, activins and follistatins
US20060003384A1 (en) Detection of measurement of antibodies to antigenic proteins in biological tissues or samples